Abstract
Breath analysis has long been recognized as a potentially attractive method for the diagnosis of several diseases. The main advantage over other diagnostic methods such as blood or urine analysis is that breath analysis is fully non-invasive, comfortable for patients and breath samples can be easily obtained. One possible future application of breath analysis may be the diagnosing and monitoring of diabetes. It is, therefore, essential, to firstly determine a relationship between exhaled biomarker concentration and glucose in blood as well as to compare the results with the results obtained from non-diabetic subjects. Concentrations of molecules which are biomarkers of diseases’ states, or early indicators of disease should be well documented, i.e., the variations of abnormal concentrations of breath biomarkers with age, gender and ethnic issues need to be verified. Furthermore, based on performed measurements it is rather obvious that analysis of exhaled acetone as a single biomarker of diabetes is unrealistic. In this paper, the author presents results of his research conducted on samples of breath gas from eleven healthy volunteers (HV) and fourteen type-1 diabetic patients (T1DM) which were collected in 1-l SKC breath bags. The exhaled acetone concentration was measured using mass spectrometry (HPR-20 QIC, Hiden Analytical, Warrington, UK) coupled with a micropreconcentrator in LTCC (Low Temperature Cofired Ceramic). However, as according to recent studies the level of acetone varies to a significant extent for each blood glucose concentration of single individuals, a direct and absolute relationship between blood glucose and acetone has not been proved. Nevertheless, basing on the research results acetone in diabetic breath was found to be higher than 1.11 ppmv, while its average concentration in normal breath was lower than 0.83 ppmv.
Highlights
Breath analysis has been developing for many years and there have been many instances of research into its potential for diagnosing diseases, e.g., diabetes [1,2,3,4,5]
The measurement results confirmed the statement that the exhaled acetone concentration for non-diabetic is less than 1 ppmv
The exhaled acetone concentration was in 0.52–3.12 ppmv range in both investigated groups
Summary
Breath analysis has been developing for many years and there have been many instances of research into its potential for diagnosing diseases, e.g., diabetes [1,2,3,4,5]. Diabetes is diagnosed on a basis of glucose concentration in blood. Breath analysis has concentrated on acetone as a biomarker of diabetes [8,9,10]. An overview of the studies of breath analysis in diabetes, focusing on the breath metabolites and their potential utilization in clinical applications, is widely discussed and presented [12]. Careful studies using an appropriate trace gas analytical methods are necessary to the same extent as certified sampling procedures to reduce different outcomes for nominally similar analytical methodologies. The sampling guidance for the breath research community is one of the challenge of the International Association of Breath Research (IABR)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
